TP53 and small cell lung carcinoma: The loss of RB and p53 functions in nearly all SCLC tumors led to the generation of a genetically engineered mouse model (GEMM) in which the mouse orthologous genes Rb1 and Trp53 were conditionally deleted using intratracheally instilled adenoviral Cre29 (Fig. 4a).